HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Koezuka Selected Research

KRN 7000 (KRN7000)

9/2001In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
4/2000Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.
4/2000[Anti-tumor activity of KRN7000, an alpha-galactosylceramide and its action mechanism].
2/2000Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
1/2000Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Koezuka Research Topics

Disease

6Neoplasms (Cancer)
08/2000 - 01/2000
3Neoplasm Metastasis (Metastasis)
10/2001 - 01/2000
2Multiple Sclerosis
12/2001 - 05/2000
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2001 - 09/2001
2Colitis
03/2001 - 07/2000
2Liver Neoplasms (Liver Cancer)
08/2000 - 01/2000
1Cardiovascular Diseases (Cardiovascular Disease)
07/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2001
1Carcinoma (Carcinomatosis)
10/2001
1Prostatic Neoplasms (Prostate Cancer)
10/2001
1Melanoma (Melanoma, Malignant)
09/2001
1Myocarditis (Carditis)
05/2001
1Virus Diseases (Viral Diseases)
05/2001
1Encephalitis (Encephalitis, Rasmussen)
05/2001
1Leukemia
04/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2001
1Malaria
07/2000
1Infections
07/2000
1Body Weight (Weight, Body)
07/2000
1Diarrhea
07/2000
1Hemorrhage
07/2000
1Inflammation (Inflammations)
07/2000
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2000
1Autoimmune Diseases (Autoimmune Disease)
02/2000
1Experimental Melanoma
01/2000

Drug/Important Bio-Agent (IBA)

13alpha-galactosylceramideIBA
10/2001 - 01/2000
5KRN 7000 (KRN7000)IBA
09/2001 - 01/2000
3AntigensIBA
12/2001 - 02/2000
2Interleukin-12 (IL 12)IBA
10/2001 - 01/2000
2LipidsIBA
10/2001 - 05/2001
2LigandsIBA
09/2001 - 04/2001
2GlycolipidsIBA
07/2000 - 07/2000
1Interleukin-4 (Interleukin 4)IBA
10/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2001
1Monoclonal AntibodiesIBA
04/2001
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
03/2001
1Glucosylceramides (Glucocerebrosides)IBA
08/2000
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2000
1Dextrans (Dextran)FDA Link
07/2000
1GlycosphingolipidsIBA
05/2000
1GangliosidesIBA
05/2000
1PerforinIBA
02/2000

Therapy/Procedure

1Prostheses and Implants (Prosthesis)
07/2008
1Immunotherapy
08/2000